Epistem Holdings Plc, the biotechnology and personalised medicine company, announced in the August update that the final results to June 2011 are anticipated to be profitable and broadly in line with market forecasts. The company expects to announce its results on the 11th of October.

The EHP share price has increased by 9.35% over the last year.

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here